thiazolidines has been researched along with Cardiovascular Stroke in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HZ; Gao, RF; Gao, Y; Li, X; Luo, W; Lv, CY; Sun, XL; Tang, YH; Xiang, HY; Yang, H; Yang, JS; Yang, YQ | 1 |
Adachi, Y; Akima, M; Fukazawa, M; Kato, T; Suzuki, Y; Tamura, K | 1 |
Rossi, G | 1 |
Bogaty, P; Kingma, JG; Plante, S | 1 |
4 other study(ies) available for thiazolidines and Cardiovascular Stroke
Article | Year |
---|---|
The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Diterpenes, Kaurane; Fibrosis; Furans; Heterocyclic Compounds, 4 or More Rings; Indenes; Inflammasomes; Interleukin-1beta; Macrophages; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocytes, Cardiac; Neutrophil Infiltration; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Interleukin-18; Signal Transduction; Stroke Volume; Sulfonamides; Sulfones; Thiazolidines; Thiones; Ventricular Function, Left; Ventricular Remodeling | 2021 |
CP-060S, a novel cardioprotective drug, limits myocardial infarct size in anesthetized dogs.
Topics: Animals; Calcium Channel Blockers; Cardiovascular Agents; Dogs; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Thiazoles; Thiazolidines | 1998 |
[Superaspirin in the platelet aggregation inhibitor therapy].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine | 1997 |
Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion.
Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Flow Cytometry; Heart; Hemodynamics; Hyperemia; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Oligopeptides; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines | 2000 |